JP2022507514A5 - - Google Patents
Info
- Publication number
- JP2022507514A5 JP2022507514A5 JP2021526509A JP2021526509A JP2022507514A5 JP 2022507514 A5 JP2022507514 A5 JP 2022507514A5 JP 2021526509 A JP2021526509 A JP 2021526509A JP 2021526509 A JP2021526509 A JP 2021526509A JP 2022507514 A5 JP2022507514 A5 JP 2022507514A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- compound according
- cancer
- compound
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862768565P | 2018-11-16 | 2018-11-16 | |
| US62/768,565 | 2018-11-16 | ||
| US201962908965P | 2019-10-01 | 2019-10-01 | |
| US62/908,965 | 2019-10-01 | ||
| PCT/US2019/061750 WO2020102686A1 (en) | 2018-11-16 | 2019-11-15 | Erk inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022507514A JP2022507514A (ja) | 2022-01-18 |
| JP2022507514A5 true JP2022507514A5 (enExample) | 2022-12-09 |
Family
ID=70730924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526509A Pending JP2022507514A (ja) | 2018-11-16 | 2019-11-15 | Ｅｒｋインヒビター及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12428416B2 (enExample) |
| EP (1) | EP3880677A4 (enExample) |
| JP (1) | JP2022507514A (enExample) |
| KR (1) | KR20210130701A (enExample) |
| CN (1) | CN113423707A (enExample) |
| AU (1) | AU2019381808A1 (enExample) |
| BR (1) | BR112021009430A2 (enExample) |
| CA (1) | CA3119988A1 (enExample) |
| IL (1) | IL283106A (enExample) |
| MX (1) | MX2021005171A (enExample) |
| SG (1) | SG11202104404XA (enExample) |
| WO (1) | WO2020102686A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4212531A1 (en) * | 2022-01-14 | 2023-07-19 | AGV Discovery | Azaindole derivatives and their use as erk kinase inhibitors |
| TW202508595A (zh) | 2023-05-04 | 2025-03-01 | 美商銳新醫藥公司 | 用於ｒａｓ相關疾病或病症之組合療法 |
| US20250049810A1 (en) | 2023-08-07 | 2025-02-13 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| AU2024360465A1 (en) | 2023-10-12 | 2026-04-09 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| TW202547461A (zh) | 2024-05-17 | 2025-12-16 | 美商銳新醫藥公司 | Ｒａｓ抑制劑 |
| WO2025255438A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR049333A1 (es) * | 2004-04-02 | 2006-07-19 | Vertex Pharma | Azaindoles inhibidores de proteinquinasas rock y otras proteinas quinasas. composiciones farmaceuticas. |
| ZA200700751B (en) | 2004-06-30 | 2008-08-27 | Vertex Pharma | Azalndoles useful as inhibitors of protein kinases |
| UA95244C2 (ru) * | 2005-06-22 | 2011-07-25 | Плексикон, Инк. | Соединения и способ модулирования активности киназ, и показания для их применения |
| DE102008031517A1 (de) * | 2008-07-03 | 2010-01-07 | Merck Patent Gmbh | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate |
| ES2402087T3 (es) * | 2008-07-23 | 2013-04-26 | Vertex Pharmaceuticals Incorporated | Inhibidores de la pirazolopiridina quinasa |
| DE102009043260A1 (de) | 2009-09-28 | 2011-04-28 | Merck Patent Gmbh | Pyridinyl-imidazolonderivate |
| DE102009060174A1 (de) * | 2009-12-23 | 2011-06-30 | Merck Patent GmbH, 64293 | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate |
| WO2012094313A1 (en) | 2011-01-04 | 2012-07-12 | Kinentia Biosciences Llc | Pyrazole derivatives as erk inhibitors |
| US9096598B2 (en) | 2011-10-03 | 2015-08-04 | Merck Sharp & Dohme Corp. | Azaindoles as Janus kinase inhibitors |
| MX2015004615A (es) * | 2012-10-16 | 2015-07-17 | Hoffmann La Roche | Inhibidores de serina/treonina cinasa. |
| WO2014109414A1 (ja) | 2013-01-11 | 2014-07-17 | 富士フイルム株式会社 | 含窒素複素環化合物またはその塩 |
| SG11201602572YA (en) * | 2013-10-03 | 2016-04-28 | Kura Oncology Inc | Inhibitors of erk and methods of use |
| WO2016026078A1 (en) * | 2014-08-19 | 2016-02-25 | Changzhou Jiekai Pharmatech Co., Ltd. | Heterocyclic compounds as erk inhibitors |
| EP3247353A4 (en) * | 2015-01-23 | 2018-07-04 | Confluence Life Sciences, Inc. | Heterocyclic itk inhibitors for treating inflammation and cancer |
| EP3170822A1 (en) | 2015-11-18 | 2017-05-24 | AGV Discovery | Azaindole derivatives and their use as erk kinase inhibitors |
| CN107973783B (zh) * | 2016-10-21 | 2024-09-06 | 正大天晴药业集团股份有限公司 | 作为erk抑制剂的苯胺嘧啶衍生物 |
| CN108948002A (zh) | 2017-05-19 | 2018-12-07 | 厦门大学 | 五元并六元氮杂芳环类化合物、其制备方法、药用组合物及其应用 |
-
2019
- 2019-11-15 BR BR112021009430-0A patent/BR112021009430A2/pt not_active Application Discontinuation
- 2019-11-15 US US17/294,225 patent/US12428416B2/en active Active
- 2019-11-15 KR KR1020217018334A patent/KR20210130701A/ko not_active Withdrawn
- 2019-11-15 MX MX2021005171A patent/MX2021005171A/es unknown
- 2019-11-15 WO PCT/US2019/061750 patent/WO2020102686A1/en not_active Ceased
- 2019-11-15 CA CA3119988A patent/CA3119988A1/en active Pending
- 2019-11-15 CN CN201980085273.1A patent/CN113423707A/zh active Pending
- 2019-11-15 JP JP2021526509A patent/JP2022507514A/ja active Pending
- 2019-11-15 EP EP19884483.9A patent/EP3880677A4/en not_active Withdrawn
- 2019-11-15 AU AU2019381808A patent/AU2019381808A1/en not_active Abandoned
- 2019-11-15 SG SG11202104404XA patent/SG11202104404XA/en unknown
-
2021
- 2021-05-11 IL IL283106A patent/IL283106A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022507514A5 (enExample) | ||
| RU2376287C2 (ru) | Производные бензамида, способ их получения и их применение, фармацевтическая композиция и способ обеспечения ингибирующего действия по отношению к hdac | |
| JP2020503299A5 (enExample) | ||
| JP2009536620A5 (enExample) | ||
| RU2405780C2 (ru) | Химические соединения | |
| JP2022062168A5 (enExample) | ||
| RU2008122048A (ru) | Аминопиримины в качестве ингибиторов киназ | |
| JP2018507877A5 (enExample) | ||
| CA2545427A1 (en) | Selective kinase inhibitors | |
| CA2651363A1 (en) | Triazolopyrazine derivatives useful as anti-cancer agents | |
| RU2017145026A (ru) | Соединение, ингибирующее brk | |
| JP2006503082A5 (enExample) | ||
| JP2007517807A5 (enExample) | ||
| JP2017503000A5 (enExample) | ||
| JP2017509586A5 (enExample) | ||
| RU2016110096A (ru) | Новое хинолин-замещенное соединение | |
| CY1118846T1 (el) | Τριαζολοπυριδαζινες ως ρυθμιστες της κινασης τυροσινης | |
| JP2016053042A5 (enExample) | ||
| RU2011124304A (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| JP2007538092A5 (enExample) | ||
| RU2016141934A (ru) | Ингибиторы циклин-зависимой киназы 7 (cdk7) | |
| JP2010509356A5 (enExample) | ||
| RU2009140407A (ru) | СОЕДИНЕНИЯ ИМИДАЗ[1, 2-a]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ РЕЦЕПТОРНЫХ ТИРОЗИНКИНАЗ | |
| AR051342A1 (es) | Derivados de purina, purinona, deazapurina y deazapurinona como inhibidores de la actividad de la protein quinasa; metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en la elaboracion de un medicamento para el tratamiento de enfermedades mediadas por la protein quina | |
| PE20140411A1 (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis |